Pulse Brain · Growing Health Evidence Index
Tier 4 — Narrative / commentaryPeer-reviewed

Omega-3 Polyunsaturated Fatty Acids in Cancer Cachexia and Inflammation: Mechanisms and Delivery Innovations.

Cintoni M, Leonardi E, Meo E, Raoul PC, Palombaro M, Rinninella E, Parroni L, Capristo E, Gasbarrini A, Mele MC.

Nutrients · 2026

Read source ↗ All evidence

Summary

This narrative review synthesises mechanistic and clinical evidence for omega-3 PUFAs (EPA and DHA) in managing cancer-associated cachexia and chronic systemic inflammation. In experimental models, EPA and DHA suppress pro-inflammatory cytokine synthesis, remodel the tumour microenvironment, inhibit tumour cell proliferation, and attenuate skeletal muscle catabolism; in patients, reduction in circulating inflammatory biomarkers is the most consistent finding. Meta-analysis of randomised trials in advanced non-small cell lung cancer suggests that ≥2 g EPA+DHA daily for ≥6 weeks may yield modest gains in body weight and quality-of-life, though this signal is inconsistent across individual trials and large negative trials in mixed cancer populations.

Regional applicability

The review draws on international clinical trial evidence and mechanistic studies applicable to UK oncology practice, but does not focus on UK-specific population or healthcare context. Findings are relevant to supporting UK cancer patients with cachexia and inflammation, though implementation depends on integrating omega-3 PUFA supplementation into current UK cancer care pathways and protocols.

Key measures

Pro-inflammatory cytokine synthesis; tumor microenvironment remodeling; tumor cell proliferation; apoptosis induction; skeletal muscle catabolism markers (ubiquitin-proteasome system, IGF-1/PI3K/Akt/mTOR axis); circulating inflammatory biomarkers; body weight; quality-of-life scores; bioavailability and pharmacokinetics across molecular forms.

Outcomes reported

The review examined mechanistic rationale and clinical evidence for omega-3 PUFAs (EPA and DHA) as adjunctive nutritional support in cancer-associated cachexia and chronic inflammation, synthesising findings from experimental models, randomised controlled trials, systematic reviews, and meta-analyses. It evaluated bioavailability across different molecular forms and delivery platforms (oral, enteral, parenteral, and nanotechnology-based).

Theme
Nutrition & health
Subject
Dietary fats & fatty acids
Study type
Narrative Review
Study design
Narrative review
Source type
Peer-reviewed study
Status
Published
System type
Human clinical
DOI
10.3390/nu18213464
Catalogue ID
NRmwpajltw-002

Topic tags

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.